Skip to content
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact
Menu
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact

Cancer Res. 2004 Dec 15;64(24

Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL

  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact
Menu
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact
Menu
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact

© 2023 Scopus BioPharma. All rights reserved | Privacy Policy | Cookies Policy